191 filings
Page 5 of 10
8-K
yhj dkl53n35io2f0
10 May 22
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:07pm
DEFA14A
s9bo3hkgcq lubxhb5f
28 Apr 22
Additional proxy soliciting materials
4:39pm
8-K
7dctqjqk
27 Apr 22
Amendments to Articles of Incorporation or Bylaws
4:09pm
S-8
6i0zynrk9ge yq1fsq
28 Mar 22
Registration of securities for employees
5:17pm
8-K
kyop44u4
28 Mar 22
Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm
8-K
h4ml psbse7k9f
17 Feb 22
Departure of Directors or Certain Officers
4:30pm
8-K
wmig6 7y9
20 Dec 21
Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab
4:15pm
8-K
x7rce5rh2fa
22 Nov 21
Entry into a Material Definitive Agreement
5:06pm
424B5
52o1tujg3b
22 Nov 21
Prospectus supplement for primary offering
4:45pm
8-K
pirk g42u6984o64
10 Nov 21
Progenity Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:05pm
8-K
bhw sahucoiizmoa
9 Nov 21
Progenity Appoints Adi Mohanty as Chief Executive Officer
6:35am
8-K
lg8x ooe8r40
4 Nov 21
Progenity Announces Appointment of Jill Howe to its Board of Directors
6:39am
8-K
asbekz4vtv22iz2va
27 Oct 21
Other Events
7:31am
424B5
rezafjq1ymeg40kp6qv
26 Oct 21
Prospectus supplement for primary offering
4:32pm
8-K
xszvvmryl7vt xz4tjyw
26 Oct 21
Unregistered Sales of Equity Securities
7:30am
8-K
5fxi2g8h tib
6 Oct 21
Entry into a Material Definitive Agreement
4:11pm